nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.208	0.456	CbGbCtD
Triamterene—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.166	0.365	CbGbCtD
Triamterene—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0813	0.179	CbGbCtD
Triamterene—Irreversible renal failure—Cisplatin—peripheral nervous system neoplasm	0.075	0.141	CcSEcCtD
Triamterene—Renal failure chronic—Cisplatin—peripheral nervous system neoplasm	0.0262	0.0493	CcSEcCtD
Triamterene—Azotaemia—Vincristine—peripheral nervous system neoplasm	0.015	0.0282	CcSEcCtD
Triamterene—Lamotrigine—ABCB1—peripheral nervous system neoplasm	0.0121	1	CrCbGaD
Triamterene—Photosensitivity—Tretinoin—peripheral nervous system neoplasm	0.00905	0.017	CcSEcCtD
Triamterene—Photosensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00905	0.017	CcSEcCtD
Triamterene—Renal failure acute—Tretinoin—peripheral nervous system neoplasm	0.0086	0.0162	CcSEcCtD
Triamterene—Renal failure acute—Isotretinoin—peripheral nervous system neoplasm	0.0086	0.0162	CcSEcCtD
Triamterene—Renal failure acute—Melphalan—peripheral nervous system neoplasm	0.00849	0.016	CcSEcCtD
Triamterene—Hyperkalaemia—Cisplatin—peripheral nervous system neoplasm	0.00694	0.013	CcSEcCtD
Triamterene—Photosensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00686	0.0129	CcSEcCtD
Triamterene—Renal failure acute—Alitretinoin—peripheral nervous system neoplasm	0.00652	0.0122	CcSEcCtD
Triamterene—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00627	0.0118	CcSEcCtD
Triamterene—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00627	0.0118	CcSEcCtD
Triamterene—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00589	0.0111	CcSEcCtD
Triamterene—Renal failure acute—Cisplatin—peripheral nervous system neoplasm	0.00556	0.0104	CcSEcCtD
Triamterene—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00475	0.00892	CcSEcCtD
Triamterene—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00467	0.00877	CcSEcCtD
Triamterene—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00458	0.0086	CcSEcCtD
Triamterene—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00398	0.00748	CcSEcCtD
Triamterene—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00398	0.00748	CcSEcCtD
Triamterene—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00394	0.00739	CcSEcCtD
Triamterene—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0039	0.00733	CcSEcCtD
Triamterene—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0039	0.00733	CcSEcCtD
Triamterene—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00385	0.00724	CcSEcCtD
Triamterene—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00385	0.00724	CcSEcCtD
Triamterene—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00382	0.00718	CcSEcCtD
Triamterene—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00382	0.00718	CcSEcCtD
Triamterene—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00377	0.00709	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.00357	0.0067	CcSEcCtD
Triamterene—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00353	0.00663	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—peripheral nervous system neoplasm	0.00343	0.00644	CcSEcCtD
Triamterene—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00339	0.00637	CcSEcCtD
Triamterene—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00337	0.00632	CcSEcCtD
Triamterene—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00337	0.00632	CcSEcCtD
Triamterene—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00332	0.00624	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.0033	0.0062	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.00317	0.00595	CcSEcCtD
Triamterene—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00312	0.00587	CcSEcCtD
Triamterene—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00567	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.003	0.00564	CcSEcCtD
Triamterene—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00296	0.00556	CcSEcCtD
Triamterene—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0029	0.00545	CcSEcCtD
Triamterene—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0029	0.00544	CcSEcCtD
Triamterene—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00288	0.0054	CcSEcCtD
Triamterene—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00288	0.0054	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00285	0.00536	CcSEcCtD
Triamterene—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00285	0.00536	CcSEcCtD
Triamterene—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00284	0.00533	CcSEcCtD
Triamterene—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00282	0.0053	CcSEcCtD
Triamterene—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0028	0.00526	CcSEcCtD
Triamterene—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0028	0.00526	CcSEcCtD
Triamterene—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00279	0.00524	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00278	0.00521	CcSEcCtD
Triamterene—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00277	0.00519	CcSEcCtD
Triamterene—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00275	0.00517	CcSEcCtD
Triamterene—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00269	0.00506	CcSEcCtD
Triamterene—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00267	0.00502	CcSEcCtD
Triamterene—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00267	0.00502	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.00496	CcSEcCtD
Triamterene—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00264	0.00495	CcSEcCtD
Triamterene—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0026	0.00489	CcSEcCtD
Triamterene—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00258	0.00485	CcSEcCtD
Triamterene—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00258	0.00485	CcSEcCtD
Triamterene—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.00479	CcSEcCtD
Triamterene—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00252	0.00474	CcSEcCtD
Triamterene—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0025	0.0047	CcSEcCtD
Triamterene—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00466	CcSEcCtD
Triamterene—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00466	CcSEcCtD
Triamterene—Rash—Topotecan—peripheral nervous system neoplasm	0.00248	0.00466	CcSEcCtD
Triamterene—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00248	0.00466	CcSEcCtD
Triamterene—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00464	CcSEcCtD
Triamterene—Headache—Topotecan—peripheral nervous system neoplasm	0.00247	0.00463	CcSEcCtD
Triamterene—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.00462	CcSEcCtD
Triamterene—Rash—Tretinoin—peripheral nervous system neoplasm	0.00246	0.00462	CcSEcCtD
Triamterene—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00246	0.00462	CcSEcCtD
Triamterene—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.00462	CcSEcCtD
Triamterene—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00246	0.00462	CcSEcCtD
Triamterene—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00245	0.0046	CcSEcCtD
Triamterene—Headache—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00459	CcSEcCtD
Triamterene—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00459	CcSEcCtD
Triamterene—Rash—Melphalan—peripheral nervous system neoplasm	0.00243	0.00456	CcSEcCtD
Triamterene—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00243	0.00456	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.0024	0.0045	CcSEcCtD
Triamterene—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00235	0.00442	CcSEcCtD
Triamterene—Nausea—Topotecan—peripheral nervous system neoplasm	0.00234	0.00439	CcSEcCtD
Triamterene—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00436	CcSEcCtD
Triamterene—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00436	CcSEcCtD
Triamterene—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00231	0.00434	CcSEcCtD
Triamterene—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00229	0.0043	CcSEcCtD
Triamterene—Nausea—Melphalan—peripheral nervous system neoplasm	0.00229	0.0043	CcSEcCtD
Triamterene—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00226	0.00425	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00222	0.00417	CcSEcCtD
Triamterene—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00218	0.0041	CcSEcCtD
Triamterene—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00409	CcSEcCtD
Triamterene—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00399	CcSEcCtD
Triamterene—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0021	0.00395	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00208	0.0039	CcSEcCtD
Triamterene—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00205	0.00384	CcSEcCtD
Triamterene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00203	0.00381	CcSEcCtD
Triamterene—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00202	0.0038	CcSEcCtD
Triamterene—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00201	0.00378	CcSEcCtD
Triamterene—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00199	0.00374	CcSEcCtD
Triamterene—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00372	CcSEcCtD
Triamterene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00368	CcSEcCtD
Triamterene—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00195	0.00366	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00361	CcSEcCtD
Triamterene—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0019	0.00356	CcSEcCtD
Triamterene—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00189	0.00354	CcSEcCtD
Triamterene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00353	CcSEcCtD
Triamterene—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00187	0.0035	CcSEcCtD
Triamterene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.0035	CcSEcCtD
Triamterene—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00186	0.00349	CcSEcCtD
Triamterene—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00348	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00344	CcSEcCtD
Triamterene—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00181	0.00341	CcSEcCtD
Triamterene—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00181	0.0034	CcSEcCtD
Triamterene—Rash—Vincristine—peripheral nervous system neoplasm	0.0018	0.00338	CcSEcCtD
Triamterene—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.0018	0.00337	CcSEcCtD
Triamterene—Headache—Vincristine—peripheral nervous system neoplasm	0.00179	0.00336	CcSEcCtD
Triamterene—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.0033	CcSEcCtD
Triamterene—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00173	0.00324	CcSEcCtD
Triamterene—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0017	0.0032	CcSEcCtD
Triamterene—Nausea—Vincristine—peripheral nervous system neoplasm	0.00169	0.00318	CcSEcCtD
Triamterene—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00166	0.00311	CcSEcCtD
Triamterene—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0016	0.00301	CcSEcCtD
Triamterene—Rash—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00299	CcSEcCtD
Triamterene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00298	CcSEcCtD
Triamterene—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00158	0.00297	CcSEcCtD
Triamterene—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00153	0.00287	CcSEcCtD
Triamterene—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00281	CcSEcCtD
Triamterene—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00147	0.00276	CcSEcCtD
Triamterene—Rash—Etoposide—peripheral nervous system neoplasm	0.00146	0.00274	CcSEcCtD
Triamterene—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00145	0.00273	CcSEcCtD
Triamterene—Headache—Etoposide—peripheral nervous system neoplasm	0.00145	0.00272	CcSEcCtD
Triamterene—Nausea—Etoposide—peripheral nervous system neoplasm	0.00137	0.00258	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00248	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00243	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00238	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.0023	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00225	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.0022	CcSEcCtD
Triamterene—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00112	0.0021	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00194	CcSEcCtD
Triamterene—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000954	0.00179	CcSEcCtD
Triamterene—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000929	0.00174	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000886	0.00166	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000883	0.00166	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.00161	CcSEcCtD
Triamterene—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00161	CcSEcCtD
Triamterene—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000823	0.00155	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00082	0.00154	CcSEcCtD
Triamterene—Rash—Epirubicin—peripheral nervous system neoplasm	0.000816	0.00153	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000816	0.00153	CcSEcCtD
Triamterene—Headache—Epirubicin—peripheral nervous system neoplasm	0.000811	0.00152	CcSEcCtD
Triamterene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00149	CcSEcCtD
Triamterene—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000769	0.00144	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.00143	CcSEcCtD
Triamterene—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.00142	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.00142	CcSEcCtD
Triamterene—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.00141	CcSEcCtD
Triamterene—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.00134	CcSEcCtD
